BPA Call W9098S13A0014-0011

The Department of the Navy Bureau of Medicine and Surgery awarded a $12,039 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA reagent. Microgenics, a Clinical Diagnostics Division of Thermo Electron Corporation, will deliver the requested products from its location in Fremont, California to support the Bureau's testing programs. No set-aside provisions were applied to this competitive award issued under an unspecified government-wide acquisition contract...

The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide two specific laboratory products - the LightCycler Uracil-DNA Glycosylase 1.5mL and the KIT RMS dNTP Blend. This sole-source contract, valued at $148,748.00, was procured under the commercial items guidelines of Federal Acquisition Regulation (FAR) Part 12. The contract has no set-aside designation. Roche...

The Department of the Navy Bureau of Medicine and Surgery (DoD - Navy) awarded Roche Diagnostics Corporation a $1.13 million definitive contract to provide LightCycler products and services. The firm fixed price contract runs from September 30, 2022 through September 29, 2025 and will be performed in Castleton, Indiana. LightCycler is a real-time PCR system used for genetic and infectious disease testing. Roche Diagnostics Corporation will serve as the prime contractor to provide these...

This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, with a ceiling value of $12,045.47, is a Blanket Purchase Agreement (BPA) call placed against the Medical Command's (MEDCOM) laboratory reagents contract (Contract IDs W91YTZ23A0012 and W91YTZ25F0011) for the delivery of laboratory reagents. The contract has no set-aside designation and is a...

The Defense Health Agency awarded a firm fixed price delivery order worth $18,058.50 to Microgenics Corporation for DRI ECSTASY PLUS 500 ML MDMA/MDA reagents. The products will support the Tripler Army Medical Center in Hawaii, with delivery required by May 9, 2023. Microgenics Corporation, a division of Thermo Electron Corporation, will perform as the prime contractor without a set-aside designation. The reagents will aid drug identification and toxicology testing conducted by the Defense...

The Department of the Navy Bureau of Medicine and Surgery awarded a $5,016.25 firm fixed price delivery order contract to Microgenics Corporation for DRI-ECSTASY PLUS 500ML MDMA/MDA REAGENT. As the clinical diagnostics division of Thermo Electron Corporation, Microgenics will deliver the requested MDMA/MDA reagent product to a location in Fremont, California by the completion date of June 3, 2021. No set-aside designation was used for this award to the prime contractor Microgenics. The Bureau of...

The Department of the Navy Bureau of Medicine and Surgery awarded a $12,039 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA REAGENT. Microgenics, a division of Thermo Electron Corporation, will provide the requested reagents under the contract for use at the place of performance in Fremont, California by September 16, 2021. No set-aside provisions were applied to this award to supply diagnostic test products in support of the Navy Bureau of Medicine and...

This is a $97,000 firm fixed-price purchase order contract awarded by the Medical Command of the U.S. Department of Defense to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 SYSTEM, with a completion date of December 11, 2020. This contract was awarded without a set-aside designation and is part of the federal government's National Interest...

The Department of the Army Medical Command awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation for $133,791.86 to provide LIAT Analyzers for the rapid identification of influenza and respiratory syncytial virus (RSV). The contract, which did not have a set-aside designation, was awarded on September 27, 2017 with a completion date of September 30, 2019. Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory...

Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, was awarded a Blanket Purchase Agreement (BPA) call by the Defense Health Agency to provide reagents, consumables, and equipment such as HSV probes and primers, CMV and viral hepatitis testing kits, system wash reagent, and laboratory instruments like the MagNA Pure LC 2.0 and LightCycler 2.0. The $220,000.00 contract has a firm fixed price and provides these critical care diagnostics and equipment to support healthcare...